IACS-6274 is well tolerated and biologically active in selected advanced tumours Presented ByDr Timothy Yap, MD Anderson Cancer Center, TX, USA TrialPhase 1 ConferenceASCO 2021 TypePeer-reviewed article 12 August 2021 22:55